MODIVCARE INC (MODV)

US60783X1046 - Common Stock

11.13  +0.24 (+2.2%)

After market: 11.13 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MODV. MODV was compared to 109 industry peers in the Health Care Providers & Services industry. MODV may be in some trouble as it scores bad on both profitability and health. MODV is valued correctly, but it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year MODV was profitable.
In the past year MODV has reported a negative cash flow from operations.
In the past 5 years MODV reported 4 times negative net income.
In multiple years MODV reported negative operating cash flow during the last 5 years.

1.2 Ratios

MODV has a worse Return On Assets (-11.08%) than 71.30% of its industry peers.
The Return On Invested Capital of MODV (1.43%) is comparable to the rest of the industry.
MODV had an Average Return On Invested Capital over the past 3 years of 3.11%. This is significantly below the industry average of 8.15%.
Industry RankSector Rank
ROA -11.08%
ROE N/A
ROIC 1.43%
ROA(3y)-4.51%
ROA(5y)-2.36%
ROE(3y)-47.21%
ROE(5y)-26.92%
ROIC(3y)3.11%
ROIC(5y)4.49%

1.3 Margins

MODV has a Operating Margin (0.84%) which is comparable to the rest of the industry.
MODV's Operating Margin has declined in the last couple of years.
MODV has a worse Gross Margin (15.52%) than 69.44% of its industry peers.
In the last couple of years the Gross Margin of MODV has grown nicely.
Industry RankSector Rank
OM 0.84%
PM (TTM) N/A
GM 15.52%
OM growth 3Y-46.23%
OM growth 5Y-13.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.58%
GM growth 5Y18.19%

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MODV is destroying value.
MODV has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, MODV has more shares outstanding
The debt/assets ratio for MODV is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.53, we must say that MODV is in the distress zone and has some risk of bankruptcy.
MODV has a Altman-Z score (1.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.53
ROIC/WACC0.22
WACC6.38%

2.3 Liquidity

A Current Ratio of 0.80 indicates that MODV may have some problems paying its short term obligations.
With a Current ratio value of 0.80, MODV is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
MODV has a Quick Ratio of 0.80. This is a bad value and indicates that MODV is not financially healthy enough and could expect problems in meeting its short term obligations.
MODV has a Quick ratio of 0.80. This is in the lower half of the industry: MODV underperforms 76.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8

3

3. Growth

3.1 Past

The earnings per share for MODV have decreased strongly by -74.84% in the last year.
MODV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.87% yearly.
Looking at the last year, MODV shows a small growth in Revenue. The Revenue has grown by 3.16% in the last year.
Measured over the past years, MODV shows a quite strong growth in Revenue. The Revenue has been growing by 14.71% on average per year.
EPS 1Y (TTM)-74.84%
EPS 3Y-6.06%
EPS 5Y17.87%
EPS Q2Q%-68.75%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y26.2%
Revenue growth 5Y14.71%
Sales Q2Q%2.2%

3.2 Future

MODV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.72% yearly.
The Revenue is expected to grow by 4.66% on average over the next years.
EPS Next Y-81.85%
EPS Next 2Y-34.22%
EPS Next 3Y-12.72%
EPS Next 5YN/A
Revenue Next Year1.93%
Revenue Next 2Y4.07%
Revenue Next 3Y4.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

MODV is valuated cheaply with a Price/Earnings ratio of 6.87.
Based on the Price/Earnings ratio, MODV is valued cheaper than 98.15% of the companies in the same industry.
MODV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.73.
The Price/Forward Earnings ratio is 4.58, which indicates a rather cheap valuation of MODV.
Based on the Price/Forward Earnings ratio, MODV is valued cheaper than 100.00% of the companies in the same industry.
MODV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.87
Fwd PE 4.58

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MODV is valued cheaply inside the industry as 80.56% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.23

4.3 Compensation for Growth

MODV's earnings are expected to decrease with -12.72% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.38
EPS Next 2Y-34.22%
EPS Next 3Y-12.72%

0

5. Dividend

5.1 Amount

MODV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MODIVCARE INC

NASDAQ:MODV (12/20/2024, 8:25:15 PM)

After market: 11.13 0 (0%)

11.13

+0.24 (+2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners101.55%
Inst Owner Change-3.23%
Ins Owners16.27%
Ins Owner Change23.38%
Market Cap158.94M
Analysts81.67
Price Target25.5 (129.11%)
Short Float %3.87%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-73.46%
Min EPS beat(2)-103.84%
Max EPS beat(2)-43.07%
EPS beat(4)0
Avg EPS beat(4)-73.41%
Min EPS beat(4)-145.64%
Max EPS beat(4)-1.07%
EPS beat(8)2
Avg EPS beat(8)-31.46%
EPS beat(12)5
Avg EPS beat(12)-15.2%
EPS beat(16)8
Avg EPS beat(16)-7.92%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-3.73%
Max Revenue beat(2)-2.34%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-3.73%
Max Revenue beat(4)1.08%
Revenue beat(8)4
Avg Revenue beat(8)0.28%
Revenue beat(12)7
Avg Revenue beat(12)1.37%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)-7.98%
PT rev (3m)-36.17%
EPS NQ rev (1m)-35.94%
EPS NQ rev (3m)-57.24%
EPS NY rev (1m)-33.41%
EPS NY rev (3m)-53.74%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)-2.57%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 6.87
Fwd PE 4.58
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 8.23
EPS(TTM)1.62
EY14.56%
EPS(NY)2.43
Fwd EY21.85%
FCF(TTM)-6.69
FCFYN/A
OCF(TTM)-4.35
OCFYN/A
SpS195.21
BVpS-1.19
TBVpS-69.95
PEG (NY)N/A
PEG (5Y)0.38
Profitability
Industry RankSector Rank
ROA -11.08%
ROE N/A
ROCE 2.2%
ROIC 1.43%
ROICexc 1.48%
ROICexgc 6.8%
OM 0.84%
PM (TTM) N/A
GM 15.52%
FCFM N/A
ROA(3y)-4.51%
ROA(5y)-2.36%
ROE(3y)-47.21%
ROE(5y)-26.92%
ROIC(3y)3.11%
ROIC(5y)4.49%
ROICexc(3y)3.27%
ROICexc(5y)5.07%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)5.74%
ROICexcg growth 3Y-42.77%
ROICexcg growth 5Y3.04%
ROICexc growth 3Y-40.46%
ROICexc growth 5Y-21.72%
OM growth 3Y-46.23%
OM growth 5Y-13.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.58%
GM growth 5Y18.19%
F-Score4
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 9.18
Cap/Depr 30.6%
Cap/Sales 1.2%
Interest Coverage 0.31
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 1.53
F-Score4
WACC6.38%
ROIC/WACC0.22
Cap/Depr(3y)36.92%
Cap/Depr(5y)44.44%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.84%
EPS 3Y-6.06%
EPS 5Y17.87%
EPS Q2Q%-68.75%
EPS Next Y-81.85%
EPS Next 2Y-34.22%
EPS Next 3Y-12.72%
EPS Next 5YN/A
Revenue 1Y (TTM)3.16%
Revenue growth 3Y26.2%
Revenue growth 5Y14.71%
Sales Q2Q%2.2%
Revenue Next Year1.93%
Revenue Next 2Y4.07%
Revenue Next 3Y4.66%
Revenue Next 5YN/A
EBIT growth 1Y-11.19%
EBIT growth 3Y-32.14%
EBIT growth 5Y-1.06%
EBIT Next Year223.82%
EBIT Next 3Y52%
EBIT Next 5YN/A
FCF growth 1Y-487.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-207.85%
OCF growth 3YN/A
OCF growth 5YN/A